U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06804785) titled 'Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)' on Nov. 25, 2024.
Brief Summary: The purpose of this study is to develop a new way to diagnose prostate cancer through the use of artificial intelligence. The goal is for this new method to reduce delays in diagnoses and to avoid invasive procedures such as biopsies.
Study Start Date: Jan., 2025
Study Type: OBSERVATIONAL
Condition:
Prostate Cancer
Recruitment Status: RECRUITING
Sponsor: Northwestern University
Disclaimer: Curated by HT Syndication....